Impact of Recombinant DNA Technology and Protein Engineering on Structure-Based Drug Design: Case Studies of HIV-1 and HCMV Proteases

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|2|3|247-269

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.2, Iss.3, 2002-03, pp. : 247-269

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Accommodating Protein Flexibility for Structure-Based Drug Design

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 2, 2011-01 ,pp. : 171-178

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery of HIV-1 Integrase Inhibitors through a Novel Combination of Ligand and Structure-based Drug Design

By  

Medicinal Chemistry, Vol. 1, Iss. 3, 2005-05 ,pp. : 263-275

Bentham Science Publishers

Access to resources Recommend Favorite

Challenges and opportunities for new protein crystallization strategies in structure-based drug design

By Grey Jessica Lynn   Thompson David H  

Expert Opinion on Drug Discovery, Vol. 5, Iss. 11, 2010-11 ,pp. : 1039-1045

Informa Healthcare

Access to resources Recommend Favorite

From Laptop to Benchtop to Bedside: Structure-based Drug Design on Protein Targets

By  

Current Drug Metabolism, Vol. 18, Iss. 9, 2012-03 ,pp. : 1217-1239

Bentham Science Publishers

Access to resources Recommend Favorite

From Laptop to Benchtop to Bedside: Structure-based Drug Design on Protein Targets

By  

Current Pharmaceutical Design, Vol. 18, Iss. 9, 2012-03 ,pp. : 1217-1239

Bentham Science Publishers

Access to resources Recommend Favorite